Skip to content

Clinical trials

Hemophilia A trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia A Country / region: Belgium Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20053
20061
20082
20092
20103
20113
20121
20131
20142
20151
20162
20174
20184
20192
20203
20216
20221
20234
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Recruiting5
Active, not recruiting4
Terminated4
Withdrawn2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer7
Hoffmann-La Roche5
Novo Nordisk A/S5
Baxalta now part of Shire4
Cliniques universitaires Saint-Luc- Université Catholique de Louvain3
Pfizer3
Wyeth is now a wholly owned subsidiary of Pfizer3
BioMarin Pharmaceutical2
Bioverativ Therapeutics Inc.2
Bioverativ, a Sanofi company2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia A50
Hemophilia B11
Blood Coagulation Disorders3
Coagulation Protein Disorders3
Genetic Diseases, Inborn3
Hematologic Diseases3
Hemorrhagic Disorders3
Blood Coagulation Disorders, Inherited2
Hemostatic Disorders2
Joint Diseases2

Trials

Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.